New hope for tough leukemia: trial tests promising drug combo
Disease control
Recruiting now
This study is testing whether adding a new drug called L-Annamycin to a standard chemotherapy (cytarabine) works better than the standard chemo alone for adults with acute myeloid leukemia (AML) that has come back or didn't respond to first treatment. The goal is to put the cance…
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC